Previous study reported that serum CRH levels were higher and skin CRHR1 gene expressions were lower in affected samples from AD patients, as compared with healthy controls, overstimulation by the increased serum levels of CRH, leads to decreased gene expressions of skin CRH and CRHR1[36], meanwhile, activated mast cells directly[37]. This evidence concerns the gene CRHR1 and Alzheimer disease.